These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6602765)
1. Immunospecificities of antinuclear antibody in systemic connective tissue diseases in India. Narayanan K; Rajagopalan P; Malaviya AN Indian J Med Res; 1983 Jan; 77():87-95. PubMed ID: 6602765 [No Abstract] [Full Text] [Related]
2. [Antibodies to soluble nuclear antigens and native DNA in patients with connective tissue diseases with antinuclear antibodies]. Damilano G; Hübscher O; Fernández L; Arana RM Medicina (B Aires); 1983; 43(5):488-94. PubMed ID: 6371438 [No Abstract] [Full Text] [Related]
3. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases]. Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516 [No Abstract] [Full Text] [Related]
4. [Diagnostic value of antinuclear and anti-native-DNA antibodies in connective tissue diseases]. Guzmán L; González C; Arriagada M; Grisanti M; Meléndez M; Arinoviche R Rev Med Chil; 1982 Jan; 110(1):24-8. PubMed ID: 6760312 [No Abstract] [Full Text] [Related]
5. [Antinuclear antibodies, anti-SSA(Ro) and SSB(La) in diffuse connective tissue diseases]. Assad RL; Gabriel Júnior A; Iglesias SS; Cossermelli W Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):103-8. PubMed ID: 3551017 [No Abstract] [Full Text] [Related]
11. [Connective tissue diseases and HEp-2 antinuclear antibodies]. Scagliusi P; Anelli P; Fasiello V; De Lucia M; Pipitone V Minerva Med; 1985 May; 76(21):999-1003. PubMed ID: 3873632 [TBL] [Abstract][Full Text] [Related]
12. Fatal connective tissue disease with antinuclear antibodies following PUVA therapy. Bruze M; Krook G; Ljunggren B Acta Derm Venereol; 1984; 64(2):157-60. PubMed ID: 6203306 [TBL] [Abstract][Full Text] [Related]
13. Comparison of substrates for the detection of antinuclear antibodies in normals and in patients with connective tissue and other diseases. Lipscomb MF; Cope LD; Stephens GL; Deng JS; Gilliam JN Diagn Immunol; 1984; 2(3):181-7. PubMed ID: 6388982 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of antibodies against extractible nuclear antigens (ENA) with a view to "mixed connective tissue syndrome" (author's transl)]. Zitnan D; Cebecauer L; Miceková D; Lukác J; Rovenský J; Tauchmannová H Cas Lek Cesk; 1980; 119(8):227-33. PubMed ID: 6966537 [No Abstract] [Full Text] [Related]
15. Evaluation of antinuclear antibody (ANA) in ANA-associated connective tissue diseases. Lee AY; Hudspeth AR; Ray U J Clin Pathol; 2015 Oct; 68(10):853-4. PubMed ID: 26063813 [No Abstract] [Full Text] [Related]
17. [Detection and antigenic characterization of antinuclear antibodies in connective tissue inflammation]. de Marneffe P; Malaise M; Deflandre E; Hauwaert C; Lallemand MP; Franchimont P Rev Med Liege; 1989 Oct; 44(19):577-91. PubMed ID: 2682916 [No Abstract] [Full Text] [Related]
18. [Epidermal nuclear fluorescence of normal skin in connective tissue diseases]. Wollina U; Koch HJ; Knopf B Dermatol Monatsschr; 1984; 170(11):699-702. PubMed ID: 6394393 [No Abstract] [Full Text] [Related]
19. The role of the laboratory in rheumatology. Antibodies to nuclear and other intracellular antigens in the connective tissue diseases. Alarcón-Segovia D Clin Rheum Dis; 1983 Apr; 9(1):161-75. PubMed ID: 6191908 [No Abstract] [Full Text] [Related]
20. [Positive immunofluorescence reaction in cell nuclei in the undamaged skin of patients with systemic connective tissue diseases]. Plesivcnik M; Vizjak A; Rozman B; Pisek K; Kveder T; Lestan B Reumatizam; 1988; 35(1-6):7-17. PubMed ID: 3077198 [No Abstract] [Full Text] [Related] [Next] [New Search]